Cryopreserved ampule of Human Dental Pulp Stem Cells containing ≥1 million cells
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells with cell population frequency information
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells with cell population frequency information
Human CD19+ B cells isolated from peripheral blood using negative immunomagnetic selection, cryopreserved, ≥10 million cells
Cryopreserved ampule of Prostate Epithelial Cells (PrEC) containing ≥500,000 cells
Cryopreserved ampule of Human Mesenchymal Stem Cells (hMSCs) containing ≥750,000 cells
Cryopreserved ampule of Human Subcutaneous Preadipocytes containing ≥4 million cells
Cryopreserved ampule of Human Aortic Endothelial Cells (HAEC) containing ≥ 500,000 cells
-
Formulation - RPMI 1640 MediumComposition of RPMI 1640 (12-918)
-
Formulation - RPMI 1640 MediumComposition of RPMI 1640 (04-525)
-
Formulation - RPMI 1640 Medium (12-167, 08-012)Components present in RPMI 1640 (12-167)
-
Formulation - RPMI 1640 MediumComponents present in RPMI 1640 (12-702)
-
Formulation - RPMI 1640 Medium (BE12-702)Components present in RPMI 1640 (BE12-702)
-
Formulation - RPMI 1640 MediumComponents present in RPMI 1640 (12-115)
-
Formulation - RPMI 1640 MediumComponents present in RPMI 1640 Medium (09-774).
-
TechSheet – RPMI 1640 MediumLonza_BenchGuides_RPMI_1640.pdf
-
Webinar – Efficient Transfection of Biologically Relevant Cells in Immunology Research (pdf)Lonza_Webinars_Webinar__Efficient_Transfection_of_Biologically_Relevant_Cells_in_Immunology_Research.pdf
-
Developing Patient-specific Cell Therapy Manufacturing ProcessesPoster presentation about patient-specific cellular therapies and their tremendous potential for being able to treat life threatening diseases where there are currently no cures.